Legacy Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$364K Buy
+5,209
New +$389K 0.03% 213
2026
Q2
– Sell
-1,755
Closed -$207K – 348
2026
Q1
$207K Buy
1,755
+53
+3% +$6.55K 0.02% 266
2025
Q4
$214K Buy
+1,702
New +$222K 0.02% 266
2025
Q1
$3.95M Buy
23,966
+351
+1% +$58.4K 0.41% 49
2024
Q4
$3.85M Buy
23,615
+6,661
+39% +$1.19M 0.37% 45
2024
Q3
$3.31M Buy
16,954
+2,044
+14% +$377K 0.36% 53
2024
Q2
$2.58M Buy
14,910
+3,392
+29% +$564K 0.31% 63
2024
Q1
$1.95M Buy
11,518
+8,252
+253% +$1.55M 0.25% 74
2023
Q4
$645K Buy
3,266
+69
+2% +$12.2K 0.08% 174
2023
Q3
$556K Buy
3,197
+81
+3% +$14.7K 0.09% 177
2023
Q2
$537K Buy
+3,116
New +$539K 0.08% 167
2017
Q4
– Sell
-61
Closed -$3K – 439
2017
Q3
$3K Buy
+61
New +$3.82K ﹤0.01% 317

Other funds holding ZTS

Legacy Advisors's ZTS Position: Q3 2026 in Review

Legacy Advisors opened a new position in Zoetis (ZTS) in Q3 2026: 5,209 shares worth $364K. The stake represents 0.03% of the portfolio and ranks #213 among its holdings. This is a return to the name: Legacy Advisors previously reported a position in ZTS as recently as Q1 2026.

Legacy Advisors first reported a position in ZTS in Q3 2017 and has held it in 12 quarters since. The position peaked at $3.95M in Q1 2025. 683 funds tracked by Wall St. Rank hold ZTS as of Q3 2026.

  • Legacy Advisors held 5,209 shares of Zoetis worth $364K as of Q3 2026.
  • Zoetis was a new Legacy Advisors position in Q3 2026.
  • Zoetis made up 0.03% of Legacy Advisors's portfolio in Q3 2026, its #213 holding.
  • Legacy Advisors first reported a position in Zoetis in Q3 2017 and has held it in 12 quarters since.
  • Legacy Advisors's Zoetis position peaked at $3.95M in Q1 2025.
  • 683 funds tracked by Wall St. Rank held Zoetis as of Q3 2026.

Based on Legacy Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.